Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Chronic Migraine Epidemiology and Outcomes Study

This study has been completed.
Information provided by (Responsible Party):
Allergan Identifier:
First received: July 20, 2012
Last updated: January 17, 2014
Last verified: January 2014

This is a population internet-based study to characterize migraine clinical course and impact on family.

Condition Intervention
Migraine Disorders
Other: No Treatment

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective

Resource links provided by NLM:

Further study details as provided by Allergan:

Primary Outcome Measures:
  • Migraine Disability Assessment (MIDAS) [ Time Frame: 13 Months ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Subject Quality of Life Questionnaire [ Time Frame: 13 Months ] [ Designated as safety issue: No ]

Enrollment: 16789
Study Start Date: July 2012
Study Completion Date: November 2013
Primary Completion Date: November 2013 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
Subjects with migraine and household members
Other: No Treatment
No Treatment


Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Subjects with chronic migraine


Inclusion Criteria:

  • History of migraine
  • U.S. Member of Survey Panel
  • Household member of study participant
  • Ability to complete internet-based questionnaires

Exclusion Criteria:

  • No access to internet
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01648530

Sponsors and Collaborators
Study Director: Medical Director Allergan
  More Information

No publications provided

Responsible Party: Allergan Identifier: NCT01648530     History of Changes
Other Study ID Numbers: GMA-BTX-12-470
Study First Received: July 20, 2012
Last Updated: January 17, 2014
Health Authority: United States: Institutional Review Board

Additional relevant MeSH terms:
Migraine Disorders
Brain Diseases
Central Nervous System Diseases
Headache Disorders
Headache Disorders, Primary
Nervous System Diseases processed this record on November 27, 2014